Table 2.

In vitro antimicrobial activity of the synthesized compounds

Comp.	Antimicrobial screening (MIC = µM)
	SA	BS	EC	KP	ST	CA	AN
1	81.1	40.5	81.1	40.5	40.5	40.5	40.5
2	101.2	50.6	50.6	50.6	50.6	50.6	50.6
3	77.3	38.6	77.3	38.6	38.6	38.6	38.6
4	18.2	36.5	73.0	36.5	36.5	36.5	36.5
5	36.5	36.5	73.0	36.5	36.5	36.5	36.5
6	40.0	40.0	80.1	40.0	40.0	40.0	40.0
7	38.8	38.8	77.6	38.8	38.8	38.8	38.8
8	77.6	38.8	77.6	38.8	38.8	38.8	38.8
9	37.2	37.2	74.4	18.6	18.6	37.2	37.2
10	74.4	18.6	74.4	37.2	37.2	37.2	37.2
11	38.3	38.3	19.2	38.3	38.3	38.3	38.3
12	32.2	32.2	64.5	32.2	32.2	16.1	32.2
13	17.9	35.9	70.8	17.9	35.9	17.9	17.9
14	64.6	32.3	64.6	32.3	32.3	32.3	32.3
15	74.0	37.0	74.0	37.0	18.5	18.5	18.5
16	74.0	18.5	37.0	37.0	37.0	37.0	37.0
17	74.0	37.0	74.0	37.0	74.0	37.0	37.0
18	76.6	38.3	38.3	38.3	38.3	38.3	38.3
19	35.9	35.9	35.9	35.9	35.9	35.9	35.9
20	31.3	31.3	62.5	31.3	31.3	31.3	31.3
Cefadroxil	34.4	34.4	17.2	34.4	34.4	–	–
Fluconazole	–	–	–	–	–	40.8	40.8

Italic signifies best MIC values against selected microbial strains

SA: Staphylococcus aureus, BS: Bacillus subtilis, EC: Escherichia coli, KP: Klebsiella pneumoniae, ST: Salmonella typhi; CA: Candida albicans, AN: Aspergillus niger